CPAP Devices Market Size

CPAP Devices Market Analysis

The CPAP Devices Market size is estimated at USD 4.38 billion in 2024, and is expected to reach USD 6.46 billion by 2029, growing at a CAGR of 8.10% during the forecast period (2024-2029).

Factors such as the rising burden of sleep disorders and respiratory diseases, technological advancements in CPAP devices, and the increasing prevalence of obesity and hypertension are expected to boost the growth of the CPAP devices market over the forecast period.

The high incidences of sleep disorders such as sleep apnea among the population are expected to fuel the demand for CPAP devices as they deliver a steady stream of air, preventing the airway from collapsing during breathing, which reduces interruption in breathing, thus propelling market growth. For instance, according to the Global Sleep Survey 2024 report, individuals are facing disruptions in their sleep patterns in 2024 globally. Similarly, according to a study conducted in Brazil’s Sao Paulo, published in January 2024, the prevalence of obstructive sleep apnea among the Brazillian population ranged between 32.9% and 43.2% in 2022, with a higher prevalence observed in males as compared to females. Thus, the prevalence of sleep apnea raises the demand for CPAP devices, thus bolstering market growth.

Various studies have been conducted to assess the prevalence of chronic obstructive pulmonary disease (COPD) in individuals aged 40 years and older globally. For instance, according to an article published in BMC Public Health, in January 2024, the overall prevalence of COPD in people aged 40 years and older was 12.64% in 2022. The men (15.47%) had a higher prevalence of COPD compared to women (8.79%). The study demonstrated that the highest prevalence was recorded in Southeast Asian countries and the lowest prevalence was recorded in the Americas. As the number of COPD patients grows globally, the need for respiratory support rises. CPAP devices are often used to help alleviate breathing difficulties, particularly in those with moderate to severe COPD. This increases the demand for CPAP devices in both hospital and homecare settings, which is anticipated to bolster market growth over the forecast period.

Furthermore, technological advancements in CPAP devices are set to enhance their adoption, propelling market growth during the forecast period. For instance, in August 2024, Oxymed, a prominent respiratory brand in India, launched an innovative range of CPAP devices aimed at transforming sleep care. Equipped with German turbines, these devices promise exceptional durability without a steep price tag. The latest offering, the Oxymed SleepEasy Auto CPAP, is readily available through dealer networks nationwide and on major online e-commerce platforms. Building on the success of its popular i-series PAP devices, this cutting-edge device features the sophisticated FlowSens algorithm, ensuring a comfort and performance level typically reserved for international brands yet offered at a significantly reduced price. Such developments are anticipated to increase the adoption of these devices by the target population, which is expected to bolster market growth over the forecast period.

Therefore, owing to the growing burden of sleep apnea and COPD among the population, coupled with the launch of technologically advanced devices in demand, the market studied is expected to grow over the forecast period. However, due to the high cost of CPAP devices and complex regulatory and reimbursement frameworks, the market studied is likely to face some impediments over the forecast period.